NDC 50989-101 - Double A ORAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50989-101
- Package NDCs from labels
- 50989-101-25, 50989-101-17
- Manufacturer
- Vedco, Inc.
- Effective date
- 2017-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Double "A" Solution | Vedco, Inc. | 2017-01-17 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50989-101-17 | Double AORAL | 1000 mL in 1 BOTTLE | SOLUTION | 1000 | 2 | |
| 50989-101-25 | Double AORAL | 500 mL in 1 BOTTLE | SOLUTION | 500 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | LX22YL083G |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 87cc7349-5a07-4a39-be97-4e1013814f30 | 2023-02-06 | Warnings, Adverse reactions | 660YQ98I10 |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 945419b8-6184-f4f3-e053-2a95a90a6236 | 2023-01-27 | Warnings, Adverse reactions | SK47B8698T |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc. | 9f8d2886-9ecd-4cbf-a84a-2d221cb3497c | 2023-01-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Kali muriaticum | POTASSIUM CHLORIDE | Boiron | 8608d5a3-93e6-e8e2-e053-2a91aa0aaedc | 2023-01-23 | 660YQ98I10 | |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Kali Mur | KALI MURIATICUM | Energique, Inc. | db9894e6-2de0-428e-b553-11bb39a1d711 | 2023-01-04 | Warnings | 660YQ98I10 |
| KELAN | SILICON DIOXIDE, ARNICA MONTANA ROOT, GRAPHITE, HYPERICUM PERFORATUM, LEDUM PALUSTRE TWIG, MAGNESIUM FLUORIDE, MAGNESIUM SULFATE HEPTAHYDRATE, AND RUTA GRAVEOLENS FLOWERING TOP | PEKANA Naturheilmittel GmbH | 55786d99-ee1f-490f-9023-3e6c39da86b0 | 2022-12-22 | Warnings | SK47B8698T |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | International Medication Systems, Limited | fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d | 2022-12-20 | Warnings, Adverse reactions | LX22YL083G |
| KALI MURIATICUM | POTASSIUM CHLORIDE | Hyland's Inc. | 2e8a4762-d28d-4b64-892f-913e04d18d2d | 2022-12-19 | Warnings | 660YQ98I10 |
| Dr Talbots Infant Pain Fever Relief | CALENDULA OFFICINALIS 12X,CHAMOMILLA 12X,ECHINACEA ANGUSTIFOLIA 12X,EUPATORIUM PERFOLIATUM 12X,HEPAR SULPHURIS CALCAREUM 12X,SULPHUR 12X,FERRUM PHOSPHORICUM 12X,KALI MURIATICUM 6X | Talbot's Pharmaceuticals Family Products,LLC. | e881a3ce-8cf9-0ce6-e053-2995a90ae824 | 2022-12-16 | Warnings | 660YQ98I10 |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 94e9a33f-39c4-4bc5-e053-2a95a90a43ac | 2022-12-10 | Warnings, Adverse reactions | SK47B8698T |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 9947731b-fb0f-0c68-e053-2a95a90a815e | 2022-12-10 | Warnings, Adverse reactions | SK47B8698T |
| 25% Dextrose Infant | 25% DEXTROSE INFANT | HF Acquisition Co. LLC, DBA Health First | 73d04839-a2bb-65dd-e053-2991aa0a82ca | 2022-12-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 9c80dfee-8923-4d1f-85b0-98bd68b94212 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 50603082-bce5-49eb-9737-e04239cfb695 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| OSTEOBIOS | CALCITONIN HUMAN - CALCIUM CARBONATE - CALCIUM FLUORIDE - CALCIUM PHOSPHATE - ISOLEUCINE - LEUCINE - LYSINE - METHIONINE - PHENYLALANINE - SUS SCROFA BONE - SUS SCROFA PARATHYROID GLAND - THREONINE - TRYPTOPHAN - VALINE - | Guna spa | 1b8c8c83-1a46-4c0a-b883-e7dce781c5d1 | 2022-11-14 | Warnings | HG18B9YRS7 |
| Multiple Electrolytes pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | 84221110-b3f1-42f4-800c-ad1d3b330e9e | 2022-11-10 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.